First Horizon Advisors, Inc. Novavax Inc Transaction History

First Horizon Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	BUY	$36.28 - $75.29 $3,990 - $8,281	110 Added 2200.0%	115 $5,000
Q1 2022 May 10, 2022	SELL	$69.73 - $142.9 $9,204 - $18,862	-132 Reduced 96.35%	5 $0
Q4 2021 Feb 09, 2022	BUY	$134.56 - $217.97 $2,825 - $4,577	21 Added 18.1%	137 $19,000
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $15,824 - $24,081	89 Added 329.63%	116 $24,000
Q3 2021 Nov 09, 2021	SELL	$177.8 - $270.58 $15,646 - $23,811	-88 Reduced 76.52%	27 $5,000
Q1 2021 May 11, 2021	BUY	$112.98 - $319.93 $12,992 - $36,791	115 New	115 $20,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.